Objectives:
Introduction
Holmium laser enucleation of the prostate (HoLEP) has superior outcomes than traditional transurethral resection and has steadily increased in popularity since its introduction almost twenty years ago. [1] [2] [3] [4] HoLEP represents a versatile, well investigated surgery for benign prostatic hyperplasia (BPH), with virtually any size prostate amenable to treatment, including those prostates previously unsuccessfully treated by other modalities. 4 5 HoLEP involves two procedures: enucleation and morcellation. Although much of the previous literature surrounding HoLEP addresses efficiency of enucleation, morcellation also plays a vital role in overall procedural time. 6 While initial investigation noted inefficient morcellation, 1 mechanism, which extends from the tip of the blade with a guillotine action to morcellate tissue, whereas the Piranha oscillates from side to side with a serrated blade and has a curved unexposed tip to prevent from inadvertent bladder injury.
A randomized trial reported by El Tayeb et al demonstrated comparable morcellation rates between the two devices with cost favoring the Lumenis device. 7 The finding of comparable rates between the two devices is at odds with prior in vitro studies and a recent in vivo investigation. 8 9 Furthermore, in the original study by El Tayeb et al. OR time and overall cost was not explored. With the recent availability of a second morcellation device in the United States we sought to determine the current preference of morcellator, as well as a more complete picture of cost and morcellation efficiency between the two devices.
Materials and Methods
An institutional review board approved prospectively maintained database of HoLEP patients was utilized for this study. We evaluated all patients from 2013, the last year our institution exclusively used the VersaCut™ morcellator performed 233 of the procedures during this timeframe. There were no significant differences between the previous and most recent group with regards to patient age, pre-operative prostate specific antigen (PSA), renal function or pre-operative prostate volume. (Table 1) Intraoperative variables are presented in Table 2 . There was one identified small mucosal injury with the VersaCut; however, the injury did not result in prolonged catheter drainage, and no injuries were identified with the Piranha morcellator. (Figure 1 ). Qualities that impacted the preferences of one morcellator over another, in order of most to least importance were: the preferred device is safer, faster, easier to use, reusable, and less expensive (Figure 2 ).
There were no differences in responses amongst groups aside from the selection of a faster device by more experienced surgeons (p<0.02).
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Comment
In a cost analysis between the two currently available morcellators we found the Piranha morcellator to be more efficient, reducing OR morcellation times and cost, even when controlling for the expense of a disposable instrument.
Enucleated tissue weight, patient age and use of 5 alpha reductase inhibitors were similar between the two groups. Our findings differ from previous report of similar morcellation times between the two devices, which may be a reflection of the improved familiarity and ability to troubleshoot the Wolf Piranha system that comes with continued use. 7 We note that while the VersaCut morcellator blades were calculated assuming 3 uses as was noted by El Tayeb and colleagues, it is feasible to decrease the expenses by using morcellation blades greater than three times. However, as the blades are reused for large prostates, as in this series, they dull. This dulling effect decreases morcellation efficiency and wouldlikely increase operative time.
We also noted that in a survey of endourologists, of those that responded, less than half perform transurethral prostate enucleation. The preferred morcellator for the highest volume surgeons was divided equally between the Lumenis and Wolf morcellators. Furthermore, morcellator safety was the highest concern, while cost was the least concern to the surgeon. While the response rate was low, this was a similar rate to a recent survey based study by Becker et al, investigating oral anticoagulation and transurethral treatment of benign prostatic 9 obstruction. 10 To our knowledge this is the first survey investigation into morcellator preference in the endourology community.
Much of the literature surrounding HoLEP and efficiency is focused on the enucleation portion of the procedure as it is the more technically challenging aspect and can be influenced by surgical skill. Dusing et al found that enucleation efficiency continues to improve over time with surgeon experience increasing to over 1gm/min of tissue enucleation. 6 Morcellation remains an equally important aspect of the surgery; however, there is little skill associated with morcellation and the procedure is highly equipment dependent. There is potential to significantly improve overall OR efficiency if an effective morcellation device is employed.
In a recent randomized clinical trial comparing the two devices El Tayeb et al noted that the Piranha morcellator achieved a slightly higher rate of morcellation 5.6 vs 4.8, this was not significant when compared to the VersaCut TM (p=0.14). 7 The efficiency of morcellation does differ significantly with our current investigation as we noted a 7 gm/min morcellation efficiency with the Piranha compared to 4.4gm/min with the VersaCut. Our excellent morcellation efficiency noted with the Piranha most likely reflects an improved understanding of the equipment and ability to troubleshooting the device as the number of cases with the Piranha has increased at our institution. For example, we note that decreasing the oscillation rate of the Piranha to 1000/min greatly reduces difficulties morcellating dense round "beach ball" tissue. In the investigation by El Tayeb et al, the authors noted a significant cost benefit with the VersaCut TM Our investigation is not without limitations, which include the retrospective nature of this study increasing recall bias. However, all data was originally collected in a prospective manner using a maintained database. While OR room costs were calculated on a per minute basis and reusable morcellation blades calculated based on a maximum of 3 uses per blade, it is possible to increase the number of blade uses but likely at the cost of efficiency and thus, an increase in OR time. It is also possible to accumulate more costs for the procedure if multiple blades are utilized during a longer procedure regardless of morcellating system, but again this was not measured. We also note the participation of residents and fellows in all aspects of the cases, thus creating a heterogenous group with differing levels of morcellation experience in both cohorts. Finally, our survey response rate was low which can create a response bias regarding the preference of morcellator.
Conclusion
In a matched cohort comparing morcellation cost utilizing both the VersaCut™ and Piranha morcellation devices, we identified a significant increase in Reason for morcellator preference by cases per year <10 11 to 50 51 to 100 >100 Average
